Portola Pharma (PTLA) Announces Presentation, Publication of Full Phase 3 APEX Study Results in NEJM, ISTH SSC Meeting
Tweet Send to a Friend
Portola Pharmaceuticals Inc.® (Nasdaq: PTLA) announced that the full results of its pivotal Phase 3 APEX (Acute Medically Ill VTE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
